3B Future Health Fund Fund Manager Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Type

Private Equity Firm

Location

Luxembourg Luxembourg

Alternative Asset Classes

Established

2016

Firm Ownership

Captive Arm – Corporate

Investment Team Staff

Total Staff

3B Future Health Fund is an early-stage investment fund launched by The Helsinn Group, a Swiss pharmaceutical group. It focuses on providing capital to early-stage health tech companies, mainly oncology and rare disease therapeutics, in the US and Europe.

Asset Class	No. of Funds Currently Managed	Strategies
Private Equity	2	Complex Situation, Early Stage, Early Stage: Seed, Early Stage: Start-up, Growth, Venture (General)
Real Estate	-	-
Private Debt	-	-
Infrastructure	-	-
Natural Resources	-	-

Asset Class	No. of Funds Currently Managed	AuM	Date of AuM	Strategies
Hedge Funds	0			-

Want to see more?

Request a demo for full access to this profile.

7 Known Decision Makers

Position	Location	Asset Class
Associate & Investment Analyst	Luxembourg, Luxembourg	PE VC
Chairman & General Partner	Luxembourg, Luxembourg	PE
Chief Financial Officer and General Partner	Monaco, Monaco	PE
General Partner	Luxembourg, Luxembourg	PE VC
Investment Analyst	Monaco, Monaco	PE VC

Showing 5 of 7 known decision makers at 3B Future Health Fund

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

2 Private Capital Funds Managed

Fund Name	Vintage	Strategy	Status	Fund Structure	Closed Size (MN)	Target Size (MN)	Primary Region Focus
		Early Stage	First Close	Commingled			Europe
		Early Stage	Closed	Commingled			Europe

Showing 2 of 2 private capital fund managed by 3B Future Health Fund